Abstract:Fatty acids are among the major building blocks of living cells, making lipid biosynthesis a potent target for compounds with antibiotic or antineoplastic properties. We present the crystal structure of the 2.6-MDa Saccharomyces cerevisiae fatty acid synthase (FAS) multienzyme in complex with the antibiotic cerulenin, representing, to our knowledge, the first structure of an inhibited fatty acid megasynthase. Cerulenin attacks the FAS ketoacyl synthase (KS) domain, forming a covalent bond to the active site cysteine C1305. The inhibitor binding causes two significant conformational changes of the enzyme. First, phenylalanine F1646, shielding the active site, flips and allows access to the nucleophilic cysteine. Second, methionine M1251, placed in the center of the acyl-binding tunnel, rotates and unlocks the inner part of the fatty acid binding cavity. The importance of the rotational movement of the gatekeeping M1251 side chain is reflected by the cerulenin resistance and the changed product spectrum reported for S. cerevisiae strains mutated in the adjacent glycine G1250. Platensimycin and thiolactomycin are two other potent inhibitors of KSs. However, in contrast to cerulenin, they show selectivity toward the prokaryotic FAS system. Because the flipped F1646 characterizes the catalytic state accessible for platensimycin and thiolactomycin binding, we superimposed structures of inhibited bacterial enzymes onto the S. cerevisiae FAS model. Although almost all side chains involved in inhibitor binding are conserved in the FAS multienzyme, a different conformation of the loop K1413–K1423 of the KS domain might explain the observed low antifungal properties of platensimycin and thiolactomycin.

Inhibition of the Fe(4)S(4)-cluster-containing protein IspH (LytB): electron paramagnetic resonance, metallacycles, and mechanisms.

Pyridine Inhibitor Binding to the 4Fe-4S Protein A. Aeolicus IspH (lytb): a HYSCORE Investigation.

Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assay

Unveiling the Novel Characteristics of IGPD Polymer and Inhibitors Binding Affinities Using 12-6-4 LJ-type Nonbonded Mn2+ Model

Two natural compounds as potential inhibitors against the Helicobacter pylori and Acinetobacter baumannii IspD enzymes

The structure of 4-hydroxylphenylpyruvate dioxygenase complexed with 4-hydroxylphenylpyruvic acid reveals an unexpected inhibition mechanism

Discovery of Acetylene Hydratase Activity of the Iron–sulphur Protein IspH

The Active-Site [4Fe-4S] Cluster in the Isoprenoid Biosynthesis Enzyme IspH Adopts Unexpected Redox States during Ligand Binding and Catalysis

IspE Kinase as an Anti-infective Target: Role of a Hydrophobic Pocket in Inhibitor Binding

Inhibition of iron oxidation in Acidithiobacillus ferrooxidans by low-molecular-weight organic acids: Evaluation of performance and elucidation of mechanisms

Discovery and Modification of Sulfur-Containing Heterocyclic Pyrazoline Derivatives As Potential Novel Class of Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) Inhibitors

Identification and Characterization of an Allosteric Inhibitory Site on Dihydropteroate Synthase

Synthesis and Evaluation of Halogenated 5-(2-hydroxyphenyl)pyrazoles As Pseudilin Analogues Targeting the Enzyme IspD in the Methylerythritol Phosphate Pathway

Binding Model And 3d-Qsar Of 3-(2-Chloropyrid-5-Ylmethylamino)-2-Cyanoacrylates As Psii Electron Transport Inhibitor

Exploration of potential hit compounds targeting 1-deoxy-d-xylulose 5-phosphate reductoisomerase (IspC) from Acinetobacter baumannii: an in silico investigation

Molecular insights into the mechanism of 4‐hydroxyphenylpyruvate dioxygenase inhibition: enzyme kinetics, X‐ray crystallography and computational simulations

An Inhibitory Mechanism of AasS, an Exogenous Fatty Acid Scavenger: Implications for Re-Sensitization of FAS II Antimicrobials

Eliminating competition: Characterizing and eliminating competitive binding at separate sites between DAHP synthase's essential metal ion and the inhibitor DAHP oxime.

Design, Synthesis and Molecular Docking of 1,3,4-Oxadiazole-2(3H)-thione Derivatives Containing 1,4-Benzodioxane Skeleton as Potential FabH Inhibitors

Inhibition of the fungal fatty acid synthase type I multienzyme complex

Bio-rational Design of Photosystem II Inhibitors (VIII)